{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:44:05Z","timestamp":1793295845515,"version":"4.5.0"},"reference-count":35,"publisher":"Begell House","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>&lt;i&gt;Helicobacter pylori (H. pylori)&lt;\/i&gt; infection promotes the progression of gastric cancer. The purpose of this study is to investigate the effects of &lt;i&gt;H. pylori&lt;\/i&gt; infection on gastric cancer and the underlying mechanisms. mRNA levels were determined by reverse transcription quantitative PCR (RT-qPCR). Protein expression was detected by Western blot. Cell viability was detected by Cell Counting Kit-8 assay. Cell proliferation was detected by colony formation assay. Cell mobility was detected by transwell assay. The co-localization of NEDD8 activating enzyme E1 subunit 1 (NAE1) and transferrin receptor 1 (TFR1) was determined by fluorescence &lt;i&gt;in situ&lt;\/i&gt; hybridization (FISH) assay. TFR1 neddylation was determined using &lt;i&gt;in vitro&lt;\/i&gt; neddylation assay. &lt;i&gt;H. pylori&lt;\/i&gt; infection contributed to the proliferation, migration, and invasion of gastric cancer. Moreover, &lt;i&gt;H. pylori &lt;\/i&gt;infection inhibited erastin-induced ferroptosis of gastric cancer cells. &lt;i&gt;H. pylori &lt;\/i&gt;infection downregulated NAE1, which promoted the neddylation and protein stability of TFR1. Intriguingly, overexpressed NAE1 inhibited the metastasis as well as promoted the ferroptosis of gastric cancer. &lt;i&gt;H. pylori &lt;\/i&gt;infection mediates malignant behaviors of gastric cancer via inactivating NAE1\/TFR1 signaling. Therefore, targeting NAE1\/TFR1 signaling may provide a novel strategy for gastric cancer.<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2025060632","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T16:16:51Z","timestamp":1756138611000},"page":"39-49","source":"Crossref","is-referenced-by-count":1,"title":["Helicobacter pylori Suppress the Ferroptosis of Gastric Cancer via Inhibiting NAE1-Mediated Neddylation of TFR1"],"prefix":"10.1615","volume":"35","author":[{"given":"Xinguo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazati","family":"Baheti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: Implications for therapy development. Trends Cancer. 2024;10:627-42. doi: 10.1016\/j.trecan.2024.03.008.","DOI":"10.1016\/j.trecan.2024.03.008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Wang FH, Zhang XT, Tang L, Wu Q, Cai MY, Li YF, Qu XJ, Qiu H, Zhang YJ, Ying JE, Zhang J, Sun LY, Lin RB, Wang C, Liu H, Qiu MZ, Guan WL, Rao SX, Ji JF, Xin Y, Sheng WQ, Xu HM, Zhou ZW, Zhou AP, Jin J, Yuan XL, Bi F, Liu TS, Liang H, Zhang YQ, Li GX, Liang J, Liu BR, Shen L, Li J, Xu RH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun. 2024;44:127-72. doi: 10.1002\/cac2.12516.","DOI":"10.1002\/cac2.12516"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Zeng R, Gou H, Lau HCH, Yu J. Stomach microbiota in gastric cancer development and clinical implications. Gut. 2024;73:2062-73. doi: 10.1136\/gutjnl-2024-332815.","DOI":"10.1136\/gutjnl-2024-332815"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Zhang F, Yan Y, Ge C. Frailty as a predictor of adverse outcomes in patients with gastric cancer: A systematic review and meta-analysis of 75,357 patients. Ageing Res Rev. 2024;101:102528. doi: 10.1016\/j.arr.2024.102528.","DOI":"10.1016\/j.arr.2024.102528"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Chen YC, Malfertheiner P, Yu HT, Kuo CL, Chang YY, Meng FT, Wu YX, Hsiao JL, Chen MJ, Lin KP, Wu CY, Lin JT, O'Morain C, Megraud F, Lee WC, El-Omar EM, Wu MS, Liou JM. Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology. 2024;166:605-19. doi: 10.1053\/j.gastro.2023.12.022.","DOI":"10.1053\/j.gastro.2023.12.022"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Tran SC, Bryant KN, Cover TL. The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk. Gut Microbes. 2024;16:2314201. doi: 10.1080\/19490976.2024.2314201.","DOI":"10.1080\/19490976.2024.2314201"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Zhou L, Lu H, Song Z, Lyu B, Chen Y, Wang J, Xia J, Zhao Z. 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment. Chin Med J. 2022;135:2899-910. doi: 10.1097\/CM9.0000000000002546.","DOI":"10.1097\/CM9.0000000000002546"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and gastric cancer: Pathogenetic mechanisms. Int J Mol Sci. 2023;24. doi: 10.3390\/ijms24032895.","DOI":"10.3390\/ijms24032895"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424-42. doi: 10.1038\/s41580-024-00703-5.","DOI":"10.1038\/s41580-024-00703-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Cheng X, Dai E, Wu J, Flores NM, Chu Y, Wang R, Dang M, Xu Z, Han G, Liu Y, Chatterjee D, Hu C, Ying J, Du Y, Yang L, Guan X, Mo S, Cao X, Pei G, Jiang J, Lu X, Benitez AM, Waters RE, Pizzi MP, Shanbhag N, Fan Y, Peng F, Hanash SM, Calin G, Futreal A, Song S, Yee C, Mazur PK, Qin JJ, Ajani JA, Wang L. Atlas of metastatic gastric cancer links ferroptosis to disease progression and immunotherapy response. Gastroenterology. 2024;167:1345-57. doi: 10.1053\/j.gastro.2024.07.038.","DOI":"10.1053\/j.gastro.2024.07.038"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Liu J, Tang D, Kang R. Targeting GPX4 in ferroptosis and cancer: Chemical strategies and challenges. Trends Pharmacol Sci. 2024;45:666-70. doi: 10.1016\/j. tips.2024.05.006.","DOI":"10.1016\/j.tips.2024.05.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Shen C, Liu J, Liu H, Li G, Wang H, Tian H, Mao Y, Hua D. Timosaponin AIII induces lipid peroxidation and ferroptosis by enhancing Rab7-mediated lipophagy in colorectal cancer cells. Phytomedicine. 2024;122:155079. doi: 10.1016\/j.phymed.2023.155079.","DOI":"10.1016\/j.phymed.2023.155079"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Liu L, Ye Y, Lin R, Liu T, Wang S, Feng Z, Wang X, Cao H, Chen X, Miao J, Liu Y, Jiang K, Han Z, Li Z, Cao X. Ferroptosis: A promising candidate for exosome-mediated regulation in different diseases. Cell Commun Signal. 2024;22:6. doi: 10.1186\/s12964-023-01369-w.","DOI":"10.1186\/s12964-023-01369-w"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: Mechanisms and therapeutic prospects. Signal Transduct Target Ther. 2024;9:271. doi: 10.1038\/s41392-024-01969-z.","DOI":"10.1038\/s41392-024-01969-z"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Zhang D, Duque-Jimenez J, Facchinetti F, Brixi G, Rhee K, Feng WW, Janne PA, Zhou X. Transferrin receptor targeting chimeras for membrane protein degradation. Nature. 2025;638:787-95. doi: 10.1038\/s41586-024-07947-3.","DOI":"10.1038\/s41586-024-07947-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Cheng X, Fan K, Wang L, Ying X, Sanders AJ, Guo T, Xing X, Zhou M, Du H, Hu Y, Ding H, Li Z, Wen X, Jiang W, Yan X, Ji J. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer. Cell Death Dis. 2020;11:92. doi: 10.1038\/s41419-020-2272-z.","DOI":"10.1038\/s41419-020-2272-z"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Hu C, Zu D, Xu J, Xu H, Yuan L, Chen J, Wei Q, Zhang Y, Han J, Lu T, Dong J, Qin JJ, Xu Z, Cheng X. Polyphyllin B suppresses gastric tumor growth by modulating iron metabolism and inducing ferroptosis. Int J Biol Sci. 2023;19:1063-79. doi: 10.7150\/ijbs.80324.","DOI":"10.7150\/ijbs.80324"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Zhu W, Liu D, Lu Y, Sun J, Zhu J, Xing Y, Ma X, Wang Y, Ji M, Jia Y. PHKG2 regulates RSL3-induced ferroptosis in Helicobacter pylori related gastric cancer. Arch Biochem Biophys. 2023;740:109560. doi: 10.1016\/j.abb.2023.109560.","DOI":"10.1016\/j.abb.2023.109560"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Olaizola P, Lee-Law PY, Fernandez-Barrena MG, Alvarez L, Cadamuro M, Azkargorta M, O'Rourke CJ, Caballero-Camino FJ, Olaizola I, Macias RIR, Marin JJG, Serrano-Maci\u00e1 M, Martinez-Chantar ML, Avila MA, Aspichueta P, Calvisi DF, Evert M, Fabris L, Castro RE, Elortza F, Andersen JB, Bujanda L, Rodrigues PM, Perugorria MJ, Banales JM. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models. J Hepatol. 2022;77:177-90. doi: 10.1016\/j.jhep.2022.02.007.","DOI":"10.1016\/j.jhep.2022.02.007"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Arai J, Miyawaki A, Aoki T, Niikura R, Hayakawa Y, Fujiwara H, Ihara S, Fujishiro M, Kasuga M. Association Between vonoprazan and the risk of gastric cancer after Helicobacter pylori eradication. Clin Gastroenterol Hepatol. 2024;22:1217-25 e1216. doi: 10.1016\/j.cgh.2024.01.037.","DOI":"10.1016\/j.cgh.2024.01.037"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Hoft SG, Brennan M, Carrero JA, Jackson NM, Pretorius CA, Bigley TM, Saenz JB, DiPaolo RJ. Unveiling cancer-related metaplastic cells in both Helicobacter pylori infection and autoimmune gastritis. Gastroenterology. 2025;168:53-67. doi: 10.1053\/j.gastro.2024.08.032.","DOI":"10.1053\/j.gastro.2024.08.032"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Mi C, Zhao Y, Ren L, Zhang D. Inhibition of MDFI attenuates proliferation and glycolysis of Helicobacter pylori-infected gastric cancer cells by inhibiting Wnt\/beta-catenin pathway. Cell Biol Int. 2022;46:2198-206. doi: 10.1002\/cbin.11907.","DOI":"10.1002\/cbin.11907"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Koch MRA, Gong R, Friedrich V, Engelsberger V, Kretschmer L, Wanisch A, Jarosch S, Ralser A, Lugen B, Quante M, Vieth M, Vasapolli R, Schulz C, Buchholz VR, Busch DH, Mej\u00ef\u00bf\u00bdas-Luque R, Gerhard M. CagA-specific gastric CD8(+) tissue-resident T cells control Helicobacter pylori during the early infection phase. Gastroenterology. 2023;164:550-66. doi: 10.1053\/j.gastro.2022.12.016.","DOI":"10.1053\/j.gastro.2022.12.016"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Oster P, Vaillant L, Riva E, McMillan B, Begka C, Truntzer C, Richard C, Leblond MM, Messaoudene M, Machremi E, Limagne E, Ghiringhelli F, Routy B, Verdeil G, Velin D. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Gut. 2022;71:457-66. doi: 10.1136\/gutjnl-2020-323392.","DOI":"10.1136\/gutjnl-2020-323392"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Wang J, Deng R, Chen S, Deng S, Hu Q, Xu B, Li J, He Z, Peng M, Lei S, Ma T, Chen Z, Zhu H, Zuo C. Helicobacter pylori CagA promotes immune evasion of gastric cancer by upregulating PD-L1 level in exosomes. iScience. 2023;26:108414. doi: 10.1016\/j.isci.2023.108414.","DOI":"10.1016\/j.isci.2023.108414"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Shen C, Liu H, Chen Y, Liu M, Wang Q, Liu J, Liu J. Helicobacter pylori induces GBA1 demethylation to inhibit ferroptosis in gastric cancer. Mol Cell Biochem. 2025;480:1845-63. doi: 10.1007\/s11010-024-05105-x.","DOI":"10.1007\/s11010-024-05105-x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Lu Y, Sun J, Yang M, Xing Y, Zhu W, Zhu J, Ma X, Wang Y, Wang L, Jia Y. Myricetin induces ferroptosis and inhibits gastric cancer progression by targeting NOX4. J Agric Food Chem. 2024;72:6178-88. doi: 10.1021\/acs.jafc.3c05243.","DOI":"10.1021\/acs.jafc.3c05243"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Delgado TC, Barbier-Torres L, Zubiete-Franco I, Lopitz-Otsoa F, Varela-Rey M, Fernandez-Ramos D, Martinez-Chantar ML. Neddylation, a novel paradigm in liver cancer. Transl Gastroenterol Hepatol. 2018;3:37. doi: 10.21037\/tgh.2018.06.05.","DOI":"10.21037\/tgh.2018.06.05"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Chiba M, Shimono J, Suto K, Ishio T, Endo T, Goto H, Hasegawa H, Maeda M, Teshima T, Yang Y, Nakagawa M. Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia\/lymphoma. Blood. 2024;143:1379-90. doi: 10.1182\/blood.2023021423.","DOI":"10.1182\/blood.2023021423"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Jin J, Zhang R, Li J, Gao F, Liao Z, Yu Y, Wang Y, Bucci D, Xiao M, Ma R, Ma Q, Gao S, Lio J, Novais F, Huang SC, Zhu J, Ghoneim H, Wen H, Li Z, Sun N, Xin G. The NAE1-mediated neddylation operates as an essential post-translational modification checkpoint for effector CD8(+) T cells. Proc Natl Acad Sci U S A. 2025;122:e2424061122. doi: 10.1073\/pnas.2424061122.","DOI":"10.1073\/pnas.2424061122"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Ghosh DK, Ranjan A. HYPK coordinates degradation of polyneddylated proteins by autophagy. Autophagy. 2022;18:1763-84. doi: 10.1080\/15548627.2021.1997053.","DOI":"10.1080\/15548627.2021.1997053"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Fu DJ, Song J, Zhu T, Pang XJ, Wang SH, Zhang YB, Wu BW, Wang JW, Zi X, Zhang SY, Liu HM. Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo. Eur J Med Chem. 2020;192:112153. doi: 10.1016\/j.ejmech.2020.112153.","DOI":"10.1016\/j.ejmech.2020.112153"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Du Y, Fan K, Zhang H, Li L, Wang P, He J, Ding S, Yan X, Tian J. Endoscopic molecular imaging of early gastric cancer using fluorescently labeled human H-ferritin nanoparticle. Nanomedicine. 2018;14:2259-70. doi: 10.1016\/j.nano.2018.07.007.","DOI":"10.1016\/j.nano.2018.07.007"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Shen G, Jia X, Qi T, Hu Z, Xiao A, Liu Q, He K, Guo W, Zhang D, Li W, Cao G, Li G, Tian J, Huang X, Hu Y. Data-driven design of triple-targeted protein nanoprobes for multiplexed imaging of cancer lymphatic metastasis. Adv Mater. 2024;36:e2405877. doi: 10.1002\/adma.202405877.","DOI":"10.1002\/adma.202405877"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Xia M, Wu Y, Zhu H, Duan W. Tanshinone I induces ferroptosis in gastric cancer cells via the KDM4D\/p53 pathway. Hum Exp Toxicol. 2023;42:9603271231216963. doi: 10.1177\/09603271231216963","DOI":"10.1177\/09603271231216963"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/46ab5f1d315f717e\/CRE-60632.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:26:05Z","timestamp":1761283565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,6b924d6f5521c33e,46ab5f1d315f717e.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2025060632","relation":{},"ISSN":["1045-4403"],"issn-type":[{"value":"1045-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}